Insider Trades
News
businesswire.comAlpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer's Diseasebusinesswire.comJun 16
seekingalpha.comAlpha Cognition Inc. (ACOG) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 15
zacks.comAlpha Cognition Inc. (ACOG) Reports Q1 Loss, Tops Revenue Estimateszacks.comMay 14